The global swine diagnostics industry is undergoing strong expansion, supported by rising livestock production, increasing disease prevalence, and growing demand for protein-rich food products. The global swine diagnostics sector was valued at approximately US$ 194.15 billion in 2022 and is projected to reach around US$ 385.39 billion by 2030, registering a CAGR of 8.9% during the forecast period. This robust growth reflects the increasing importance of early disease detection and advanced veterinary diagnostic technologies in commercial swine farming systems worldwide.

The US Swine Diagnostics Market is a major contributor to this global expansion, driven by the country’s highly industrialized pork production system, advanced veterinary infrastructure, and strong adoption of molecular diagnostic technologies. Increasing investment in disease surveillance, coupled with rising concerns over infectious outbreaks such as PRRS and swine influenza, is further accelerating demand for rapid and accurate diagnostic solutions across the United States.

Industry Overview and Swine Health Management Framework

The US swine industry is characterized by large-scale commercial production systems that require continuous health monitoring to maintain productivity and biosecurity standards. Disease management is a critical component of farm operations, as even minor outbreaks can lead to significant economic losses due to reduced feed efficiency, mortality, and trade restrictions.

Swine diagnostics involves identifying bacterial, viral, and environmental causes of disease in pigs. In many cases, infections are multifactorial, requiring a combination of testing methods such as molecular assays, immunoassays, and serological analysis. The increasing complexity of disease patterns has made advanced diagnostics essential for effective herd management.

Modern veterinary practices in the US are increasingly relying on integrated diagnostic systems that combine laboratory testing with on-farm screening tools. This shift enables faster detection and more efficient disease control strategies, reducing the spread of infections within large pig populations.

Key Growth Drivers Supporting Market Expansion

A major growth driver in the US is the persistent burden of swine diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and porcine epidemic diarrhea. PRRS alone continues to cause substantial economic losses due to reproductive failure and respiratory complications in pigs.

Although African swine fever (ASF) has not been widely reported in the United States, global outbreaks have increased preparedness efforts and strengthened demand for surveillance diagnostics. Veterinary authorities and producers are investing in early detection systems to prevent potential outbreaks and safeguard the pork supply chain.

Government support also plays a crucial role in strengthening diagnostic capabilities. Agencies such as the United States Department of Agriculture have funded laboratory networks and disease preparedness programs aimed at improving early detection and emergency response. These initiatives are enhancing national biosecurity infrastructure and driving adoption of advanced diagnostic tools.

Additionally, rising consumer demand for safe, high-quality pork products is encouraging producers to implement stricter health monitoring protocols. This is increasing reliance on routine testing and preventive disease management strategies across commercial farms.

Disease Burden and Increasing Diagnostic Demand

The disease burden in US swine populations remains a major concern due to the rapid spread of infectious pathogens in intensive farming environments. High-density housing conditions increase the risk of viral transmission, making early diagnosis critical for effective containment.

Molecular diagnostic techniques such as PCR testing are gaining strong traction due to their high sensitivity and ability to detect pathogens at early infection stages. Immunoassay-based kits continue to be widely used for large-scale screening due to their affordability and ease of deployment.

Non-invasive sampling methods, including oral fluids and nasal swabs, are also becoming more popular. These methods reduce animal stress while improving sampling efficiency, making them suitable for routine herd monitoring programs.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00030064

Segmentation Insights in the US Swine Diagnostics Landscape

The US swine diagnostics sector is segmented by product type, disease type, sample type, and end user, each contributing to market development.

By product type, immunoassay kits dominate due to their cost-effectiveness and suitability for field testing, while PCR kits are witnessing rapid growth because of their accuracy and advanced pathogen detection capabilities.

By disease type, PRRS and respiratory diseases represent the largest share of diagnostic demand due to their widespread prevalence and significant economic impact. ASF-related testing is also gaining importance as part of national preparedness strategies.

By sample type, blood samples remain the most commonly used due to their diagnostic reliability. Oral fluids and nasal swabs are increasingly adopted for non-invasive and large-scale herd screening.

By end user, veterinary hospitals and diagnostic laboratories hold a significant share due to their advanced testing infrastructure. Large commercial farms are also increasingly adopting in-house diagnostic solutions to improve response time and reduce dependency on external laboratories.

Competitive Landscape and Technological Advancements

The US swine diagnostics sector is highly competitive, with leading global biotechnology and veterinary health companies focusing on innovation and product expansion. Companies are investing heavily in molecular diagnostics, automation technologies, and digital disease tracking systems.

Key players include:

• IDEXX Laboratories Inc
• Zoetis Inc
• Thermo Fisher Scientific Inc
• Neogen Corporation
• BioChek BV
• Bionote Inc
• INDICAL BIOSCIENCE GmbH
• Innovative Diagnostics SAS

These companies are focusing on expanding PCR-based diagnostic panels, improving immunoassay sensitivity, and integrating cloud-based data systems for real-time disease monitoring. Strategic collaborations with veterinary research institutes are also supporting the development of next-generation diagnostic solutions.

Future Outlook

The future of the US swine diagnostics landscape is expected to be shaped by continued technological innovation and increasing adoption of precision livestock farming practices. Advancements in point-of-care testing, artificial intelligence-driven disease prediction, and automated laboratory systems will significantly improve diagnostic speed and accuracy. Growing emphasis on preventive healthcare, combined with strong regulatory oversight and biosecurity initiatives, will continue to support demand. As the swine industry evolves, diagnostics will remain central to ensuring herd health, improving productivity, and maintaining a secure and sustainable pork supply chain.

Related Reports @ 

Sequencing Reagents Market Share and Forecast by 2028

Sepsis Diagnostics Market Size, Growth & Trends by 2034

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Information -

Email: [email protected]

Phone: +1-646-491-9876

Also Available in : Korean| German| Japanese| French| Chinese| Italian| Spanish